Skip to main content
  • Saved

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.

Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.

Source : https://www.ncbi.nlm.nih.gov/pubmed/31675102

OBJECTIVE: To assess the onset of efficacy for fremanezumab in chronic migraine by evaluating pain-related clinical measures at different time points. BACKGROUND: Faster onset of efficacy of preventive treatments could benefit patients with migraine. Fremanezumab is a fully humanized monoclonal antibody that selectively targets calcitonin gene-related peptide, a neuropeptide involved in the pathophysiology of migraine.

Sign In or Register Today to Access This Content